Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 16 studies | 31% ± 16% | |
oligodendrocyte precursor cell | 15 studies | 63% ± 19% | |
astrocyte | 13 studies | 39% ± 16% | |
glutamatergic neuron | 11 studies | 39% ± 26% | |
macrophage | 11 studies | 35% ± 17% | |
microglial cell | 11 studies | 43% ± 14% | |
oligodendrocyte | 11 studies | 34% ± 13% | |
adipocyte | 9 studies | 39% ± 12% | |
GABAergic neuron | 8 studies | 50% ± 21% | |
epithelial cell | 8 studies | 27% ± 15% | |
pericyte | 8 studies | 31% ± 15% | |
fibroblast | 8 studies | 27% ± 8% | |
plasmacytoid dendritic cell | 7 studies | 20% ± 4% | |
interneuron | 6 studies | 51% ± 22% | |
B cell | 6 studies | 28% ± 10% | |
natural killer cell | 5 studies | 26% ± 9% | |
neuron | 5 studies | 44% ± 18% | |
dendritic cell | 5 studies | 31% ± 12% | |
mast cell | 5 studies | 23% ± 7% | |
endothelial cell of lymphatic vessel | 5 studies | 36% ± 12% | |
monocyte | 5 studies | 26% ± 8% | |
smooth muscle cell | 5 studies | 23% ± 5% | |
granule cell | 4 studies | 39% ± 11% | |
cardiac muscle cell | 4 studies | 23% ± 4% | |
ciliated cell | 4 studies | 22% ± 9% | |
retina horizontal cell | 4 studies | 37% ± 22% | |
retinal cone cell | 4 studies | 26% ± 8% | |
T cell | 4 studies | 23% ± 6% | |
myeloid cell | 4 studies | 25% ± 7% | |
club cell | 4 studies | 27% ± 9% | |
GABAergic interneuron | 3 studies | 38% ± 11% | |
CD4-positive, alpha-beta T cell | 3 studies | 22% ± 2% | |
CD8-positive, alpha-beta T cell | 3 studies | 23% ± 3% | |
amacrine cell | 3 studies | 25% ± 12% | |
hepatocyte | 3 studies | 34% ± 22% | |
ependymal cell | 3 studies | 32% ± 12% | |
alveolar macrophage | 3 studies | 32% ± 11% | |
type I pneumocyte | 3 studies | 30% ± 8% | |
type II pneumocyte | 3 studies | 28% ± 8% | |
lymphocyte | 3 studies | 41% ± 14% | |
basal cell | 3 studies | 36% ± 22% | |
goblet cell | 3 studies | 38% ± 30% | |
transit amplifying cell | 3 studies | 36% ± 23% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 47% ± 18% | |
mural cell | 3 studies | 33% ± 16% | |
mucus secreting cell | 3 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4887.35 | 1445 / 1445 | 100% | 28.77 | 183 / 183 |
intestine | 100% | 5918.10 | 966 / 966 | 100% | 20.37 | 527 / 527 |
prostate | 100% | 5358.59 | 245 / 245 | 100% | 18.80 | 502 / 502 |
stomach | 100% | 4299.81 | 359 / 359 | 100% | 22.06 | 286 / 286 |
brain | 100% | 5153.69 | 2639 / 2642 | 100% | 23.63 | 705 / 705 |
lung | 100% | 5193.20 | 577 / 578 | 100% | 20.01 | 1154 / 1155 |
breast | 100% | 6702.72 | 459 / 459 | 100% | 28.37 | 1115 / 1118 |
bladder | 100% | 5204.43 | 21 / 21 | 100% | 18.37 | 502 / 504 |
uterus | 100% | 5766.43 | 170 / 170 | 100% | 18.84 | 457 / 459 |
ovary | 100% | 5882.65 | 180 / 180 | 99% | 16.05 | 426 / 430 |
thymus | 100% | 4749.54 | 653 / 653 | 99% | 16.77 | 599 / 605 |
kidney | 100% | 4800.62 | 89 / 89 | 98% | 18.82 | 887 / 901 |
pancreas | 99% | 3152.62 | 326 / 328 | 99% | 19.08 | 176 / 178 |
skin | 100% | 6352.83 | 1809 / 1809 | 97% | 22.35 | 460 / 472 |
liver | 100% | 2928.81 | 226 / 226 | 97% | 12.05 | 392 / 406 |
adrenal gland | 100% | 3997.63 | 258 / 258 | 93% | 9.24 | 213 / 230 |
adipose | 100% | 7291.02 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.28 | 29 / 29 |
muscle | 100% | 13047.86 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7057.18 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.61 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.93 | 1 / 1 |
blood vessel | 100% | 4736.43 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 3810.12 | 840 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 85% | 2553.46 | 789 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 8.29 | 62 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006508 | Biological process | proteolysis |
GO_0016579 | Biological process | protein deubiquitination |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
Gene name | USP24 |
Protein name | Ubiquitin specific peptidase 24 Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24) |
Synonyms | KIAA1057 |
Description | FUNCTION: Ubiquitin-specific protease that regulates cell survival in various contexts through modulating the protein stability of some of its substrates including DDB2, MCL1 or TP53. Plays a positive role on ferritinophagy where ferritin is degraded in lysosomes and releases free iron. . |
Accessions | A0A0U1RRH2 Q9UPU5 ENST00000634589.1 A0A0U1RQI9 ENST00000484447.6 ENST00000294383.7 |